Imeik Technology Development Co

Imeik Technology Development Co Graham Number

The Graham Number of Imeik Technology Development Co (300896.SZ) as of Nov 13, 2026 is 49.26 CNY. In the previous year, Graham Number was 61.61 CNY — a change of -20.05% (lower).

Graham Number

49.26CNY

YoY

-20.05%

Last updated:

Graham Number of Imeik Technology Development Co is 2025 49.26 CNY. Graham Number of Imeik Technology Development Co was 2024 61.61 CNY. It decreases by -20.05% lower compared to the previous year.

The Imeik Technology Development Co Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2018
3.48 CNY
Jan 1, 2019
8.11 CNY
Jan 1, 2020
22.41 CNY
Jan 1, 2021
34.45 CNY
Jan 1, 2022
42.69 CNY
Jan 1, 2023
54.14 CNY
Jan 1, 2024
61.61 CNY
Jan 1, 2025
49.26 CNY
The Imeik Technology Development Co Graham Number history
YEARGraham NumberYoY
49.26CNY-20.05%
61.61CNY+13.80%
54.14CNY+26.82%
42.69CNY+23.91%
34.45CNY+53.76%
22.41CNY+176.26%
8.11CNY+132.87%
3.48CNY+35.35%
2.57CNY+37.99%
1.86CNY+128.93%
0.81CNY+3.43%
0.79CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imeik Technology Development Co Stock analysis

What does Imeik Technology Development Co do? Imeik Technology Development Co., Ltd. generates revenue through the research, development, and industrialization of biomedical materials, particularly recombinant proteins and peptides. The company focuses on products like injection-type sodium hyaluronate series and polydioxanone facial implants, which are used for facial and neck skin repair in medical cosmetology, surgical repair, and metabolic disease treatment. Its self-developed products target the Chinese market, where it has established a technology transformation platform for materials such as medical chitosan and polylactic acid. The firm leverages its industrialized product lines to serve medical and cosmetic applications. The company's primary customers are healthcare providers and medical facilities in China that utilize its products for skin repair, surgical procedures, and metabolic disease management. Its product portfolio includes sodium hyaluronate series for injections, polydioxanone facial implants, and other biomedical materials like medical chitosan and polylactic acid. These products are sold under the company's own brand, with no external brands mentioned in the description. Imeik's business model centers on the industrialization of its self-developed biomedical materials, transforming research into commercial products for medical and cosmetic use. The firm's focus on recombinant proteins and peptides drives its product development, targeting applications in medical cosmetology and surgical repair. It operates within the Chinese market, where it has established a technology platform for product transformation and commercialization. Imeik Technology Development Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imeik Technology Development Co stock

Graham Number of Imeik Technology Development Co is 49.26 CNY in 2025.

On Eulerpool you can find the complete historical development of Graham Number Imeik Technology Development Co since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Imeik Technology Development Co

All Key Metrics — Imeik Technology Development Co